These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31427215)

  • 21. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
    JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Bishara H; Ore L; Vinitsky O; Bshara H; Armaly N; Weiler-Ravell D
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):799-804. PubMed ID: 26056104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
    Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of pediatric latent tuberculosis infection in a community health center clinic.
    Young J; Edick T; Klee D; O'Connor ME
    Pediatr Infect Dis J; 2012 Sep; 31(9):e147-51. PubMed ID: 22531235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis preventive therapy: perspective from a multi-ethnic community.
    Sebastian MS; Bothamley GH
    Respir Med; 2000 Jul; 94(7):648-53. PubMed ID: 10926335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment options for latent tuberculosis infection.
    Bocchino M; Matarese A; Sanduzzi A
    J Rheumatol Suppl; 2014 May; 91():71-7. PubMed ID: 24789003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
    Porter BW; Venkatappa TK
    Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil.
    Mendonça AM; Kritski AL; Sant'Anna CC
    Braz J Infect Dis; 2015; 19(3):296-301. PubMed ID: 25636186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.
    Okwara FN; Oyore JP; Were FN; Gwer S
    BMC Infect Dis; 2017 Sep; 17(1):623. PubMed ID: 28915796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spanish Society for Pediatric Infectious Diseases guidelines on tuberculosis in pregnant women and neonates (ii): Prophylaxis and treatment].
    Baquero-Artigao F; Mellado Peña MJ; del Rosal Rabes T; Noguera Julián A; Goncé Mellgren A; de la Calle Fernández-Miranda M; Navarro Gómez ML;
    An Pediatr (Barc); 2015 Oct; 83(4):286.e1-7. PubMed ID: 25754314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance to treatment of latent tuberculosis infection in a region of Israel.
    Bibi H; Weiler-Ravell D; Shoseyov D; Feigin I; Arbelli Y; Chemtob D
    Isr Med Assoc J; 2002 Jan; 4(1):13-6. PubMed ID: 11802301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of short-term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates.
    Guirao-Arrabal E; Santos F; Redel J; Vaquero JM; Torre-Cisneros J
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
    Kwara A; Herold JS; Machan JT; Carter EJ
    Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured.
    Stockbridge EL; Miller TL; Carlson EK; Ho C
    J Public Health Manag Pract; 2018; 24(4):E25-E33. PubMed ID: 29084120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
    Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study.
    Lam CK; McGinnis Pilote K; Haque A; Burzynski J; Chuck C; Macaraig M
    J Med Internet Res; 2018 Nov; 20(11):e287. PubMed ID: 30459146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.